BMY

46.07

0.99% 0.45

시장 영업 전: 46.23 0.16 +0.35%

브리스톨 마이어스 스퀴브 (BMY)

개요 뉴스 가격 이력 옵션 체인 Financials BMY 왜 하락? 토론 예측 주식 분할 배당 이력

전일 마감가:

$45.62

열려 있는:

$45.47

하루 거래량:

21.74M

Relative Volume:

1.47

시가총액:

$93.77B

수익:

$48.03B

순이익/손실:

$6.05B

주가수익비율:

15.56

EPS:

2.9615

순현금흐름:

$14.58B

1주 성능:

+5.11%

1개월 성능:

+2.15%

6개월 성능:

-8.23%

1년 성능:

-17.39%

1일 변동 폭

$45.20

$46.50

1주일 범위

$42.52

$46.50

52주 변동 폭

$42.52

$63.33

브리스톨 마이어스 스퀴브 Stock (BMY) Company Profile

명칭

Bristol Myers Squibb Co

부문

Healthcare (1135)

산업

Drug Manufacturers - General (19)

전화

(609) 252-4621

주소

ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NY

직원

34,100

트위터

@BMSNEWS

다음 수익 날짜

2024-10-31

최신 SEC 제출 서류

BMY's Discussions on Twitter

BMY을(를) 다른 주식과 비교

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
BMY Bristol Myers Squibb Co	46.07	92.86B	48.03B	6.05B	14.58B	2.9615
LLY Lilly Eli Co	862.86	757.06B	59.42B	18.41B	-50.20M	20.22
JNJ Johnson Johnson	188.87	455.48B	92.15B	25.12B	20.46B	10.36
ABBV Abbvie Inc	218.04	403.13B	58.33B	3.73B	18.24B	2.1013
NVS Novartis Ag Adr	123.79	235.26B	54.45B	14.42B	17.15B	7.333
MRK Merck Co Inc	85.98	215.51B	63.99B	19.05B	14.72B	7.5596

브리스톨 마이어스 스퀴브 Stock (BMY) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2025-08-05	다운그레이드	Daiwa Securities	Outperform → Neutral
2025-04-22	개시	Cantor Fitzgerald	Neutral
2025-04-22	개시	Piper Sandler	Overweight
2024-12-16	업그레이드	Jefferies	Hold → Buy
2024-12-10	재개	BofA Securities	Neutral
2024-11-15	개시	Wolfe Research	Peer Perform
2024-11-13	업그레이드	Daiwa Securities	Neutral → Outperform
2024-11-12	업그레이드	Leerink Partners	Market Perform → Outperform
2024-10-25	다운그레이드	Citigroup	Buy → Neutral
2024-10-17	개시	Bernstein	Mkt Perform
2024-07-29	다운그레이드	Barclays	Overweight → Equal Weight
2024-03-11	다운그레이드	Societe Generale	Buy → Hold
2024-02-06	다운그레이드	Redburn Atlantic	Buy → Neutral
2024-01-03	다운그레이드	BofA Securities	Buy → Neutral
2023-11-15	다운그레이드	Cantor Fitzgerald	Overweight → Neutral
2023-11-09	개시	Deutsche Bank	Hold
2023-11-02	다운그레이드	Daiwa Securities	Outperform → Neutral
2023-10-27	다운그레이드	BMO Capital Markets	Outperform → Market Perform
2023-10-27	업그레이드	HSBC Securities	Reduce → Hold
2023-10-27	다운그레이드	William Blair	Outperform → Mkt Perform
2023-10-20	재개	UBS	Neutral
2023-07-14	개시	HSBC Securities	Reduce
2023-07-10	개시	SVB Securities	Market Perform
2023-06-28	개시	Daiwa Securities	Outperform
2023-03-06	개시	Jefferies	Hold
2023-01-17	개시	Cantor Fitzgerald	Overweight
2022-11-18	개시	Credit Suisse	Neutral
2022-10-10	다운그레이드	Guggenheim	Buy → Neutral
2022-09-14	다운그레이드	Berenberg	Buy → Hold
2022-06-03	다운그레이드	Raymond James	Outperform → Mkt Perform
2022-04-06	재개	Morgan Stanley	Underweight
2021-12-17	개시	Goldman	Buy
2021-12-09	재개	Wells Fargo	Equal Weight
2021-11-19	개시	BMO Capital Markets	Outperform
2021-11-01	다운그레이드	Argus	Buy → Hold
2021-07-27	재개	Truist	Buy
2021-04-30	다운그레이드	Morgan Stanley	Overweight → Equal-Weight
2021-04-13	업그레이드	Truist	Hold → Buy
2020-11-16	업그레이드	Societe Generale	Hold → Buy
2020-11-10	재개	Bernstein	Mkt Perform
2020-11-06	다운그레이드	Gabelli & Co	Buy → Hold
2020-10-19	업그레이드	Guggenheim	Neutral → Buy
2020-09-29	개시	Berenberg	Buy
2020-07-28	개시	Raymond James	Outperform
2020-04-02	업그레이드	Morgan Stanley	Equal-Weight → Overweight
2020-03-23	다운그레이드	Societe Generale	Buy → Hold
2020-02-27	개시	Barclays	Equal Weight
2020-01-06	재개	Citigroup	Buy
2019-12-13	업그레이드	Argus	Hold → Buy
2019-11-22	재개	Morgan Stanley	Equal-Weight
2019-10-17	재개	BofA/Merrill	Buy
2019-08-14	업그레이드	Atlantic Equities	Neutral → Overweight
2019-05-28	개시	Goldman	Buy
2019-05-20	다운그레이드	Argus	Buy → Hold
2019-05-03	업그레이드	Barclays	Equal Weight → Overweight
2019-05-03	재개	JP Morgan	Overweight
2019-01-15	업그레이드	Societe Generale	Sell → Buy
2018-10-22	다운그레이드	Citigroup	Buy → Neutral

모두보기

브리스톨 마이어스 스퀴브 주식(BMY)의 최신 뉴스

Nov 02, 2025

How Bristol Myers Squibb Company (BRM) stock moves in volatile trading sessionsQuarterly Risk Review & Weekly Market Pulse Alerts - newser.com

Nov 02, 2025

Syverson Strege & Co Acquires New Holdings in Bristol Myers Squibb Company $BMY - MarketBeat

Nov 02, 2025

Assetmark Inc. Lowers Holdings in Bristol Myers Squibb Company $BMY - MarketBeat

Nov 02, 2025

What’s the recovery path for long term holders of Bristol Myers Squibb Company Equity RightTrade Signal Summary & Technical Pattern Alert System - newser.com

Nov 02, 2025

Bristol-Myers Squibb Company (NYSE:BMY) Q3 2025 Earnings Call Transcript - Insider Monkey

Nov 02, 2025

Nov 01, 2025

Can Bristol Myers Squibb Company stock hit record highs againExit Point & Entry Point Confirmation Signals - newser.com

Nov 01, 2025

Bristol Myers Squibb Co. Hits New 52-Week Low at $42.52 - Markets Mojo

Nov 01, 2025

Bristol Myers Squibb Company recovery potential after sell offWeekly Market Report & Risk Controlled Daily Trade Plans - newser.com

Nov 01, 2025

Is Bristol Myers Squibb Company Celegne Contingent stock a fit for income portfolios2025 Market Overview & Comprehensive Market Scan Insights - newser.com

Nov 01, 2025

Oct 31, 2025

Bristol-Myers Squibb Company (BMY.MX) stock price, news, quote and history - Yahoo! Finance UK

Oct 31, 2025

Bristol Myers Squibb (NYSE:BMY) Posts Earnings Results, Beats Expectations By $0.11 EPS - MarketBeat

Oct 31, 2025

Bristol Myers Squibb Stock Hits Day High with 7.09% Surge - Markets Mojo

Oct 31, 2025

S&P 500 Falls 0.99% Amid 1,651 Advancing Stocks; Bristol Myers Soars 7.09% - Markets Mojo

Oct 31, 2025

Bristol-Myers Squibb Tops Forecasts But Leaves Questions Unanswered - Finimize

Oct 31, 2025

Retirement Systems of Alabama Has $60.37 Million Stake in Bristol Myers Squibb Company $BMY - MarketBeat

Oct 31, 2025

New launches focus of latest financial prints at BMS, Merck & Co. - FirstWord Pharma

Oct 31, 2025

Bristol-Myers Squibb Company Confirms Efficacy and Safety of Sotyktu for Psoriatic Arthritis and Lupus with New Long-Term Data - Insider Monkey

Oct 31, 2025

Bristol-Myers Squibb Co (BMY) Q3 2025 Earnings: Revenue Surpasse - GuruFocus

Oct 31, 2025

Bristol-Myers Squibb Shares Rally on Strong Quarterly Performance - AD HOC NEWS

Oct 31, 2025

Will Bristol Myers Squibb Company (BRM) stock beat growth indexesBuy Signal & Momentum Based Trading Signals - newser.com

Oct 31, 2025

Oct 30, 2025

Bristol-Myers Squibb Company (BMY) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada

Oct 30, 2025

Research Alert: CFRA Keeps Buy View On Shares Of Bristol-myers Squibb Company - 富途牛牛

Oct 30, 2025

Bristol-Myers Squibb Company (BMY) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK

Oct 30, 2025

Bristol-Myers Sets $160 Million Tax Reserve for Transfer Pricing - news.bloombergtax.com

Oct 30, 2025

Bristol-Myers Squibb Co (BMY) Q3 2025 Earnings Call Highlights: Strong Growth and Strategic ... - Yahoo Finance

Oct 30, 2025

Bristol-Myers Squibb Company (BMY) Q3 2025 Earnings Call Transcript Summary - 富途牛牛

Oct 30, 2025

Bladder Cancer MarketGlobal and Regional Analysis and Forecast (2025-2035) Featuring Merck & Co., Bristol Myers Squibb, Astellas Pharma, AstraZeneca, and Johnson & Johnson - Yahoo Finance

Oct 30, 2025

BRISTOL MYERS SQUIBB CO SEC 10-Q Report - TradingView

Oct 30, 2025

Bristol rises on 2025 guidance raises, Q3 beats driven by Eliquis growth - MSN

Oct 30, 2025

Bristol Myers tries to temper anxiety over upcoming Cobenfy readout, unveils suite of PD-1xVEGF bispecific trials - Endpoints News

Oct 30, 2025

BMS Battles ‘Deeply Ingrained’ Prescribing Habits in Schizophrenia as Cobenfy Misses Q3 Estimates - BioSpace

Oct 30, 2025

December 12th Options Now Available For Bristol Myers Squibb (BMY) - Nasdaq

Oct 30, 2025

BMY Beats on Q3 Earnings and Sales, Raises 2025 Sales View - TradingView

Oct 30, 2025

Bristol Myers Squibb (NYSE:BMY) Surges on Q3 Earnings Beat and Raised Outlook – What’s Next for BMY Stock? - ts2.tech

Oct 30, 2025

Bristol Myers Squibb Outpaces Expectations With Strong New Drug Sales - Finimize

Oct 30, 2025

Bristol Myers beats quarterly revenue estimates on strong Opdivo sales - Reuters

Oct 30, 2025

Earnings call transcript: Bristol-Myers Squibb reports strong Q3 2025 earnings beat - Investing.com

Oct 30, 2025

Bristol Myers (BMY) Reports Q3 Earnings: What Key Metrics Have to Say - Yahoo Finance

Oct 30, 2025

CytomX Therapeutics to Report Third Quarter 2025 Financial Results on November 6, 2025 - GlobeNewswire Inc.

Oct 30, 2025

Bristol Myers: Q3 Earnings Snapshot - News-Times

Oct 30, 2025

Bristol-Myers Squibb ups annual outlook as Q3 print exceeds estimates - Investing.com Nigeria

Oct 30, 2025

Bristol Myers Beats Quarterly Expectations on Drug Demand - Bloomberg.com

Oct 30, 2025

Bristol-Myers Squibb earnings beat by $0.11, revenue topped estimates - Investing.com Canada

Oct 30, 2025

Oct 29, 2025

Bristol-Myers Squibb Q3 Earnings Preview: Pharma giant looks to reinvent growth amid patent pressure - MSN

Oct 29, 2025

Bristol-Myers Squibb and ONO Pharmaceutical’s New Study on Nivolumab for NSCLC: What Investors Need to Know - TipRanks

Oct 29, 2025

Bristol-Myers Squibb Company (BMY.MX) Stock Price, News, Quote & History - Yahoo! Finance Canada

Oct 29, 2025

Bristol Myers Squibb (NYSE:BMY) Sets New 1-Year LowHere's What Happened - MarketBeat

Oct 29, 2025

Bristol-Myers Squibb (BMY) To Report Earnings Tomorrow: Here Is What To Expect - Yahoo! Finance UK

Oct 28, 2025